Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
Clinical trial NCT02864316 · TERMINATED
Trial details
- NCT number
- NCT02864316
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.